Trials / Completed
CompletedNCT02558439
Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging 24-Week Study to Evaluate the Safety and Efficacy of a Single Injection of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 175 (actual)
- Sponsor
- Centrexion Therapeutics · Industry
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of a single injection of CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CNTX-4975 | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Completion
- 2017-02-01
- First posted
- 2015-09-24
- Last updated
- 2017-08-08
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02558439. Inclusion in this directory is not an endorsement.